NEW YORK (GenomeWeb) – Australian molecular diagnostics company Genetic Technologies announced today that it has entered into a definitive agreement with unnamed institutional investors in the US to purchase an aggregate of 4.8 million American depositary shares at an average price of $1.25 each.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more